# Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/meplazumab-treats-covid-19-pneumonia-an-open-labelled-concurrent-controlled-add/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Huijie Bian,Zhaohui Zheng,Ding Wei,Zheng Zhang,Wenzhen Kang,Chun-Qiu Hao,Ke Dong,Wen Kang,Jielai Xia,Jinlin Miao,Xie Rong-hua,Bin Wang,Xiuxuan Sun,Xiangmin Yang,Peng Lin,Jiejie Geng,Ke Wang,Hong‐Yong Cui,Kui Zhang,Xiaochun Chen,Hao Tang,Hong Du,Na Yao,Shuangshuang Liu,Linna Liu,Zhe Zhang,Zhaowei Gao,Gang Nan,Qingyi Wang,Jianqi Lian,Zhi‐Nan Chen,Ping Zhu |
| Citations | 172 |
| DOI | 10.1101/2020.03.21.20040691 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.medrxiv.org/content/medrxiv/early/2020/09/27/2020.03.21.20040691.full.pdf |
| OpenAlex ID | https://openalex.org/W3013997205 |
| Type | preprint |
| Year | 2020 |

## Paper authors

- [Ke Wang](https://scholariq.org/researchers/ke-wang/)
- [Zhaohui Zheng](https://scholariq.org/researchers/zhaohui-zheng/)

## Paper journal

- [medRxiv](https://scholariq.org/journals/medrxiv/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.